HRGN
Harvard Apparatus Regenerative Technology Inc.
Set alert
2.30 USD +0.14 +6.48%
2.23 Day range 2.30
0.96 52-week range 2.46
- YTD
- +25.00%
- 1 year
- +19.17%
- Open
- 2.24
- Prev close
- 2.16
- Mkt cap
- 46.65M
- Vol
- 1.80K
- Avg vol
- 1.59K
- EPS
- -0.39
- P/E
- 0.00
More statistics
- Low
- 2.23
- High
- 2.30
Financials — quick view
HRGN Revenue — quarterly 0
HRGN Net income — quarterly -2.61M
HRGN EPS — quarterly -0.19
News
- Harvard Apparatus Regenerative Technology Announces First Patient Treated with Cellspan Esophageal Implant at Mayo Clinic
- Harvard Apparatus Regenerative Technology Collaborates with University of Southern California to Test Treatment for Esophageal Disease
- Critical Comparison: Arch Therapeutics (OTCMKTS:ARTH) vs. Biostage (OTCMKTS:BSTG)
- Harvard Apparatus Regenerative Technology Announces Strategic Collaboration with Children's Hospital Capital institute of Pediatrics in Beijing, China to Advance Treatment for Esophageal Atresia
- Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors
- Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial
- Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
- Harvard Apparatus Regenerative Technology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Establish a Research Collaboration to Study the Repair and Regeneration of the Colon following Colectomy
- Harvard Apparatus Regenerative Technology and Renowned Professor/Physician Establish a Collaboration to Repair and Regenerate the Uterus
Your note
Sign in to keep a note on HRGN — it syncs with the Stock Master app.